Personal information

China

Activities

Employment (3)

The 910th Hospital (Affiliated Haixia Hospital of Huaqiao University): Quanzhou, Fujian, CN

2020-06-30 to present | Dr. (General Surgery)
Employment
Source: Self-asserted source
Runze Shang

Xijing Hospital: Xi’an, Shaanxi, CN

2013-09-01 to present | Dr. (Hepatobiliary Surgery)
Employment
Source: Self-asserted source
Runze Shang

UCSF Department of Bioengineering and Therapeutic Sciences: San Francisco, CA, US

2018-03 to 2020-03
Employment
Source: Self-asserted source
Runze Shang

Education and qualifications (1)

Fourth Military Medical University: Xi'an, Shaanxi, CN

2013-09 to 2020-06 | PhD (Hepatobiliary Surgery)
Education
Source: Self-asserted source
Runze Shang

Works (13)

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma.

Gut
2020-11-03 | Journal article
Source: Self-asserted source
Runze Shang

Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.

Molecular oncology
2020-03-30 | Journal article
Source: Self-asserted source
Runze Shang

mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy.

The American journal of pathology
2020-02-05 | Journal article
Source: Self-asserted source
Runze Shang

Oncogene-dependent function of BRG1 in hepatocarcinogenesis.

Cell death & disease
2020-02-04 | Journal article
Source: Self-asserted source
Runze Shang

SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model.

Cancer research
2019-08-05 | Journal article
Source: Self-asserted source
Runze Shang

The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans.

Hepatology (Baltimore, Md.)
2019-06-21 | Journal article
Source: Self-asserted source
Runze Shang

Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice.

Hepatology (Baltimore, Md.)
2019-04-11 | Journal article
Source: Self-asserted source
Runze Shang

MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment.

Cell death & disease
2019-02-11 | Journal article
Source: Self-asserted source
Runze Shang

Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma.

Cell communication and signaling : CCS
2018-12-13 | Journal article
Source: Self-asserted source
Runze Shang

FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.

Oncology reports
2017-02-22 | Journal article
Source: Self-asserted source
Runze Shang

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects.

World journal of gastroenterology
2016-12-01 | Journal article
Source: Self-asserted source
Runze Shang

The emerging landscape of circular RNA in life processes.

RNA biology
2016-08-11 | Journal article
Source: Self-asserted source
Runze Shang

RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
2015-11-06 | Journal article
Source: Self-asserted source
Runze Shang
grade
Preferred source (of 2)‎